Leflunomide + Methotrexate in Rheumatoid Arthritis

PHASE4CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

May 31, 2003

Study Completion Date

August 31, 2004

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Leflunomide

concomitantly leflunomide (no loading dose, 10 mg/day) and methotrexate (starting at 7.5 mg/week and titrating up to 15 mg/week) for 20 weeks.

Trial Locations (1)

Unknown

Sanofi-Aventis, Pusan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY